Understanding proper dosing is critical for both safety and efficacy in any peptide research program
Work with your provider to submit thorough documentation of your BMI, weight-related health conditions, and previous weight loss attempts
As of November 2025, nearly 80% (77.8%) of all Microdose GLP-1Rx users stayed engaged with the Noom app for 4 or more weeks, and D30 engagement for our December cohort was over 40% (43.6%), 1 which is at least 10 times higher than average health, medical, and fitness app retention
However, potential adverse mental health effects have also been reported and require vigilance: Nausea and gastrointestinal symptoms , common side effects of GLP-1 medications, may increase anxiety in susceptible individuals Rapid weight loss can occasionally trigger psychological distress or exacerbate eating disorder behaviours Mood changes , including low mood, have been reported in post-marketing surveillance, though causality remains uncertain Some patients report feeling emotionally flat or detached , though this is anecdotal and not well characterised in clinical trials The Summary of Product Characteristics (SmPC) for GLP-1 receptor agonists used for weight management (such as Saxenda and Wegovy) includes specific warnings about monitoring for mood disorders and suicidal thoughts
Severe Gastrointestinal Disease Active gastroparesis Severe inflammatory bowel disease History of pancreatitis (relative contraindication) Relative Contraindications (Use with Caution) 1
.png)
